COVID-19 Vaccine Hesitancy: Umbrella Review of Systematic Reviews and Meta-Analysis.

Autor:	Rahbeni TA; Molecular Toxicology and Genetics, Riyadh Elm University, Riyadh, Saudi Arabia., Satapathy P; Center for Global Health Research, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India., Itumalla R; School of Management, The Apollo University, Chittoor, India., Marzo RR; Faculty of Humanities and Health Sciences, Curtin University, Miri Sarawak, Malaysia., Mugheed KAL; Molecular Toxicology and Genetics, Riyadh Elm University, Riyadh, Saudi Arabia., Khatib MN; Division of Evidence Synthesis, Global Consortium of Public Health and Research, Datta Meghe Institute of Higher Education, Wardha, India., Gaidhane S; One Health Centre (COHERD), Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education, Wardha, India., Zahiruddin QS; South Asia Infant Feeding Research Network, Division of Evidence Synthesis, School of Epidemiology and Public Health and Research, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Wardha, India., Rabaan AA; Molecular Diagnostic Laboratory, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia.; College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.; Department of Public Health and Nutrition, The University of Haripur, Haripur, Pakistan., Alrasheed HA; Department of Pharmacy Practice, College of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia., Al-Subaie MF; Molecular Diagnostic Laboratory, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia.; Research Center, Dr Sulaiman Alhabib Medical Group, Riyadh, Saudi Arabia., Al Kaabil NA; College of Medicine and Health Science, Khalifa University, Abu Dhabi, United Arab Emirates.; Sheikh Khalifa Medical City, Abu Dhabi Health Services Company (SEHA), Abu Dhabi, United Arab Emirates., Alissa M; Department of Medical Laboratory, College of Applied Medical Sciences, Prince Sattam bin Abdulaziz University, Al-Kharj, Saudi Arabia., Ibrahim AAAL; Deparment of Pharmacy, Jubail General Hospital, Jubail, Saudi Arabia., Alsaif HA; Department of Medicine, Batterjee Medical College, Jeddah, Saudi Arabia., Naser IH; Medical Laboratories Techniques Department, AL-Mustaqbal University, Babil, Iraq., Rustagi S; School of Applied and Life Sciences, Uttaranchal University, Dehradun, India., Kukreti N; School of Pharmacy, Graphic Era Hill University, Dehradun, India., Dziedzic A; Department of Conservative Dentistry with Endodontics, Medical University of Silesia, Katowice, Poland.
Jazyk:	angličtina
Zdroj:	JMIR public health and surveillance [JMIR Public Health Surveill] 2024 Apr 30; Vol. 10, pp. e54769. Date of Electronic Publication: 2024 Apr 30.
DOI:	10.2196/54769
Abstrakt:	Background: The unprecedented emergence of the COVID-19 pandemic necessitated the development and global distribution of vaccines, making the understanding of global vaccine acceptance and hesitancy crucial to overcoming barriers to vaccination and achieving widespread immunization. Objective: This umbrella review synthesizes findings from systematic reviews and meta-analyses to provide insights into global perceptions on COVID-19 vaccine acceptance and hesitancy across diverse populations and regions. Methods: We conducted a literature search across major databases to identify systematic reviews and meta-analysis that reported COVID-19 vaccine acceptance and hesitancy. The AMSTAR-2 (A Measurement Tool to Assess Systematic Reviews) criteria were used to assess the methodological quality of included systematic reviews. Meta-analysis was performed using STATA 17 with a random effect model. The data synthesis is presented in a table format and via a narrative. Results: Our inclusion criteria were met by 78 meta-analyses published between 2021 and 2023. Our analysis revealed a moderate vaccine acceptance rate of 63% (95% CI 0.60%-0.67%) in the general population, with significant heterogeneity (I 2 = 97.59%). Higher acceptance rates were observed among health care workers and individuals with chronic diseases, at 64% (95% CI 0.57%-0.71%) and 69% (95% CI 0.61%-0.76%), respectively. However, lower acceptance was noted among pregnant women, at 48% (95% CI 0.42%-0.53%), and parents consenting for their children, at 61.29% (95% CI 0.56%-0.67%). The pooled vaccine hesitancy rate was 32% (95% CI 0.25%-0.39%) in the general population. The quality assessment revealed 19 high-quality, 38 moderate-quality, 15 low-quality, and 6 critically low-quality meta-analyses. Conclusions: This review revealed the presence of vaccine hesitancy globally, emphasizing the necessity for population-specific, culturally sensitive interventions and clear, credible information dissemination to foster vaccine acceptance. The observed disparities accentuate the need for continuous research to understand evolving vaccine perceptions and to address the unique concerns and needs of diverse populations, thereby aiding in the formulation of effective and inclusive vaccination strategies. Trial Registration: PROSPERO CRD42023468363; https://tinyurl.com/2p9kv9cr. (©Tahani Al Rahbeni, Prakasini Satapathy, Ramaiah Itumalla, Roy Rillera Marzo, Khalid A L Mugheed, Mahalaqua Nazli Khatib, Shilpa Gaidhane, Quazi Syed Zahiruddin, Ali A Rabaan, Hayam A Alrasheed, Maha F Al-Subaie, Nawal A Al Kaabil, Mohammed Alissa, Amani Ahmed A L Ibrahim, Hussain Abdulkhaliq Alsaif, Israa Habeeb Naser, Sarvesh Rustagi, Neelima Kukreti, Arkadiusz Dziedzic. Originally published in JMIR Public Health and Surveillance (https://publichealth.jmir.org), 30.04.2024.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu